Neoagarooligosaccharides enhance the level and efficiency of LDL receptor and improve cholesterol homeostasis
- 1 November 2017
- journal article
- Published by Elsevier BV in Journal of Functional Foods
- Vol. 38, 529-539
- https://doi.org/10.1016/j.jff.2017.09.053
Abstract
No abstract availableFunding Information
- Ministry of Science, ICT & Future Planning (R13-2008-010-00000-0)
This publication has 31 references indexed in Scilit:
- PCSK9: Regulation and Target for Drug Development for DyslipidemiaAnnual Review of Pharmacology and Toxicology, 2017
- Tanshinone IIA Modulates Low Density Lipoprotein Uptake via Down-Regulation of PCSK9 Gene Expression in HepG2 CellsPLOS ONE, 2016
- Familial hypercholesterolemia/autosomal dominant hypercholesterolemia: Molecular defects, the LDL-C continuum, and gradients of phenotypic severityJournal of Clinical Lipidology, 2016
- Strong induction of PCSK9 gene expression through HNF1α and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamstersJournal of Lipid Research, 2010
- Oligosaccharides from Agar Inhibit Pro-Inflammatory Mediator Release by Inducing Heme Oxygenase 1Bioscience, Biotechnology, and Biochemistry, 2010
- The LDL ReceptorArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Serum Proprotein Convertase Subtilisin Kexin Type 9 Is Correlated Directly with Serum LDL CholesterolClinical Chemistry, 2007
- Antioxidant activity and hepatoprotective potential of agaro-oligosaccharides in vitro and in vivoNutrition Journal, 2006
- Genetic Causes of Monogenic Heterozygous Familial Hypercholesterolemia: A HuGE Prevalence ReviewAmerican Journal of Epidemiology, 2004
- Statins Upregulate PCSK9 , the Gene Encoding the Proprotein Convertase Neural Apoptosis-Regulated Convertase-1 Implicated in Familial HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2004